Targeting Toll-Like Receptors for the Treatment of Lung Cancer
Author:
Publisher
Springer Nature Singapore
Link
https://link.springer.com/content/pdf/10.1007/978-981-99-7141-1_13
Reference93 articles.
1. Aberle DR, Brown K (2008) Lung cancer screening with CT. Clin Chest Med 29:1–14. v
2. Abolfathi H, Sheikhpour M, Shahraeini SS, Khatami S, Nojoumi SA (2021) Studies in lung cancer cytokine proteomics: a review. Expert Rev Proteomics 18:49–64
3. Abu Rous F, Singhi EK, Sridhar A, Faisal MS, Desai A (2023) Lung cancer treatment advances in 2022. Cancer Invest 41:12–24
4. Alexander CM, Xiong KN, Velmurugan K, Xiong J, Osgood RS, Bauer AK (2016) Differential innate immune cell signatures and effects regulated by toll-like receptor 4 during murine lung tumor promotion. Exp Lung Res 42:154–173
5. Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Javed Shaikh MA, Thangavelu L, Singh SK, Allam VSRR, Jha NK, Chellappan DK, Dua K, Gupta G (2021) Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact 345:109568
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3